Publication | Closed Access

Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate cancer

UrologyGenitourinary CancerMedicineAndrogen-independent Prostate CancerAntiandrogen TherapyCancer TreatmentProstatic DiseaseOncologyRadiation OncologyEndocrine-related CancerProstate-specific Antigen